Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos A Guzman

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Microbial Biotechnology|January 26, 2011
Optimizing rational vaccine designCarlos A Guzman
Current Opinion in Biotechnology|November 25, 2004
Pharmaceutical biotechnologyCarlos A Guzman, Giora Z Feuerstein
Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes|April 13, 2012
Catalytic ozonation of 2,4-dichlorophenoxyacetic acid using alumina in the presence of a radical scavengerCarlos A Guzman-Perez, Jafar Soltan, Jared Robertson
Plos One|July 27, 2011
Peritoneal cavity is dominated by IFNγ-secreting CXCR3+ Th1 cellsBeata M Zygmunt, Lothar Groebe, Carlos A Guzman
Plos One|February 1, 2012
NKT cell stimulation with α-galactosylceramide results in a block of Th17 differentiation after intranasal immunization in miceBeata M Zygmunt, Sebastian F Weissmann, Carlos A Guzman
Ecosal Plus|October 8, 2015
Vaccines against Infections Caused by Salmonella, Shigella, and Pathogenic Escherichia coliCarlos A Guzman, Stefan Borsutzky, Didier Favre, et al.
Bioengineered Bugs|February 18, 2011
Exploitation of prokaryotic expression systems based on the salicylate-dependent control circuit encompassing nahR/P(sal)::xylS2 for biotechnological applicationsPablo D Becker, Jose L Royo, Carlos A Guzman
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2009
Intranasal immunization promotes th17 immune responsesBeata M Zygmunt, Faiza Rharbaoui, Lothar Groebe, et al.
Journal of Virology|August 22, 2024
Intranasal administration of octavalent next-generation influenza vaccine elicits protective immune responses against seasonal and pre-pandemic virusesNaoko Uno, Thomas Ebensen, Carlos A Guzman, et al.
Frontiers in Cellular and Infection Microbiology|March 21, 2022
Editorial: The Role of Systemic and Cellular Metabolism on Susceptibility to Infections and Responsiveness to VaccinationAntonella Caputo, Carlos A Guzman, Clovis S Palmer, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Microbial Biotechnology|January 26, 2011
Optimizing rational vaccine designCarlos A Guzman
Current Opinion in Biotechnology|November 25, 2004
Pharmaceutical biotechnologyCarlos A Guzman, Giora Z Feuerstein
Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes|April 13, 2012
Catalytic ozonation of 2,4-dichlorophenoxyacetic acid using alumina in the presence of a radical scavengerCarlos A Guzman-Perez, Jafar Soltan, Jared Robertson
Plos One|July 27, 2011
Peritoneal cavity is dominated by IFNγ-secreting CXCR3+ Th1 cellsBeata M Zygmunt, Lothar Groebe, Carlos A Guzman
Plos One|February 1, 2012
NKT cell stimulation with α-galactosylceramide results in a block of Th17 differentiation after intranasal immunization in miceBeata M Zygmunt, Sebastian F Weissmann, Carlos A Guzman
Ecosal Plus|October 8, 2015
Vaccines against Infections Caused by Salmonella, Shigella, and Pathogenic Escherichia coliCarlos A Guzman, Stefan Borsutzky, Didier Favre, et al.
Bioengineered Bugs|February 18, 2011
Exploitation of prokaryotic expression systems based on the salicylate-dependent control circuit encompassing nahR/P(sal)::xylS2 for biotechnological applicationsPablo D Becker, Jose L Royo, Carlos A Guzman
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2009
Intranasal immunization promotes th17 immune responsesBeata M Zygmunt, Faiza Rharbaoui, Lothar Groebe, et al.
Journal of Virology|August 22, 2024
Intranasal administration of octavalent next-generation influenza vaccine elicits protective immune responses against seasonal and pre-pandemic virusesNaoko Uno, Thomas Ebensen, Carlos A Guzman, et al.
Frontiers in Cellular and Infection Microbiology|March 21, 2022
Editorial: The Role of Systemic and Cellular Metabolism on Susceptibility to Infections and Responsiveness to VaccinationAntonella Caputo, Carlos A Guzman, Clovis S Palmer, et al.
Pageof 9